Literature DB >> 11108964

Transcriptional regulation of S100A1 and expression during mouse heart development.

R Kiewitz1, G E Lyons, B W Schäfer, C W Heizmann.   

Abstract

S100A1, a member of the large EF-hand family of Ca(2+)-binding proteins, is mainly expressed in the mammalian heart. To assess the underlying mechanisms for cell- and tissue-specific expression we isolated and characterized the mouse S100A1 gene. The gene displays a high degree of homology to the human and rat genes, especially in the exonic sequences. In its promoter region and the first intron, we identified regulatory elements characteristic for cardiac and slow skeletal muscle restricted genes. Transfection assays with luciferase constructs containing different parts of the S100A1 gene demonstrated the active expression in primary mouse cardiomyocytes and that its 5'-upstream region containing a putative cardiac enhancer showed a greatly increased activity. Furthermore, we investigated the expression of the S100A1 mRNA during embryonic mouse development, using in situ hybridization. S100A1 transcripts were first detected in the primitive heart at embryonic day (E) 8, with equal levels in the atrium and ventricle. During development up to E17.5 we detected a shift in the S100A1 expression pattern with lower levels in atrial and high levels in ventricular myocardium. The regulatory elements identified in the mouse S100A1 promoter correspond well with the observed expression pattern and suggest that S100A1 has an important function during heart muscle development.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11108964     DOI: 10.1016/s0167-4889(00)00097-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  17 in total

1.  Impaired cardiac contractility response to hemodynamic stress in S100A1-deficient mice.

Authors:  Xiao-Jun Du; Timothy J Cole; Nora Tenis; Xiao-Ming Gao; Frank Köntgen; Bruce E Kemp; Jörg Heierhorst
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

Review 2.  Altered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy.

Authors:  Changwon Kho; Ahyoung Lee; Roger J Hajjar
Journal:  Nat Rev Cardiol       Date:  2012-10-23       Impact factor: 32.419

Review 3.  Altered myocardial calcium cycling and energetics in heart failure--a rational approach for disease treatment.

Authors:  Przemek A Gorski; Delaine K Ceholski; Roger J Hajjar
Journal:  Cell Metab       Date:  2015-02-03       Impact factor: 27.287

Review 4.  S100A1: a regulator of striated muscle sarcoplasmic reticulum Ca2+ handling, sarcomeric, and mitochondrial function.

Authors:  Mirko Völkers; David Rohde; Chelain Goodman; Patrick Most
Journal:  J Biomed Biotechnol       Date:  2010-03-28

Review 5.  S100A1: a multifaceted therapeutic target in cardiovascular disease.

Authors:  David Rohde; Julia Ritterhoff; Mirko Voelkers; Hugo A Katus; Thomas G Parker; Patrick Most
Journal:  J Cardiovasc Transl Res       Date:  2010-07-20       Impact factor: 4.132

6.  S100A1 (S100 calcium binding protein A1).

Authors:  Brian R Cannon; Danna B Zimmer; David J Weber
Journal:  Atlas Genet Cytogenet Oncol Haematol       Date:  2011-10

Review 7.  S100A1 in cardiovascular health and disease: closing the gap between basic science and clinical therapy.

Authors:  Carolin Kraus; David Rohde; Christian Weidenhammer; Gang Qiu; Sven T Pleger; Mirko Voelkers; Melanie Boerries; Andrew Remppis; Hugo A Katus; Patrick Most
Journal:  J Mol Cell Cardiol       Date:  2009-06-16       Impact factor: 5.000

Review 8.  Functions of S100 proteins.

Authors:  R Donato; B R Cannon; G Sorci; F Riuzzi; K Hsu; D J Weber; C L Geczy
Journal:  Curr Mol Med       Date:  2013-01       Impact factor: 2.222

9.  S100A1: Structure, Function, and Therapeutic Potential.

Authors:  Nathan T Wright; Brian R Cannon; Danna B Zimmer; David J Weber
Journal:  Curr Chem Biol       Date:  2009-05-01

10.  Immunohistochemical detection of S100A1 in the postmortem diagnosis of acute myocardial infarction.

Authors:  Haitao Bi; Ying Yang; Jianye Huang; Yingmin Li; Chunling Ma; Bin Cong
Journal:  Diagn Pathol       Date:  2013-05-17       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.